Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $135.3 million.

  • AdaptHealth's Shares Outstanding (Weighted Average) rose 77.59% to $135.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.3 million, marking a year-over-year increase of 77.59%. This contributed to the annual value of $133.8 million for FY2024, which is 29.82% down from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Shares Outstanding (Weighted Average) is $135.3 million, which was up 77.59% from $135.0 million recorded in Q2 2025.
  • AdaptHealth's Shares Outstanding (Weighted Average)'s 5-year high stood at $135.3 million during Q3 2025, with a 5-year trough of $126.3 million in Q4 2021.
  • Over the past 5 years, AdaptHealth's median Shares Outstanding (Weighted Average) value was $134.2 million (recorded in 2022), while the average stood at $133.6 million.
  • In the last 5 years, AdaptHealth's Shares Outstanding (Weighted Average) surged by 14063.79% in 2021 and then plummeted by 119.75% in 2024.
  • Over the past 5 years, AdaptHealth's Shares Outstanding (Weighted Average) (Quarter) stood at $126.3 million in 2021, then increased by 6.23% to $134.2 million in 2022, then decreased by 0.01% to $134.2 million in 2023, then decreased by 0.3% to $133.8 million in 2024, then increased by 1.19% to $135.3 million in 2025.
  • Its last three reported values are $135.3 million in Q3 2025, $135.0 million for Q2 2025, and $134.8 million during Q1 2025.